Home/Filings/4/0001209191-20-024314
4//SEC Filing

NEA 16 GP, LLC 4

Accession 0001209191-20-024314

CIK 0001563880other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 9:26 PM ET

Size

12.8 KB

Accession

0001209191-20-024314

Insider Transaction Report

Form 4
Period: 2020-04-03
Transactions
  • Sale

    Common Stock

    2020-04-03$2.66/sh564$1,5005,937,998 total
  • Exercise of In-Money

    Common Stock

    2020-04-03$0.00/sh+1,500,000$1,5005,938,562 total
  • Exercise of In-Money

    Call Option (right to buy)

    2020-04-031,500,0000 total
    Exercise: $0.00From: 2019-05-09Exp: 2022-05-06Common Stock (1,500,000 underlying)
Transactions
  • Exercise of In-Money

    Call Option (right to buy)

    2020-04-031,500,0000 total
    Exercise: $0.00From: 2019-05-09Exp: 2022-05-06Common Stock (1,500,000 underlying)
  • Sale

    Common Stock

    2020-04-03$2.66/sh564$1,5005,937,998 total
  • Exercise of In-Money

    Common Stock

    2020-04-03$0.00/sh+1,500,000$1,5005,938,562 total
Transactions
  • Sale

    Common Stock

    2020-04-03$2.66/sh564$1,5005,937,998 total
  • Exercise of In-Money

    Call Option (right to buy)

    2020-04-031,500,0000 total
    Exercise: $0.00From: 2019-05-09Exp: 2022-05-06Common Stock (1,500,000 underlying)
  • Exercise of In-Money

    Common Stock

    2020-04-03$0.00/sh+1,500,000$1,5005,938,562 total
Footnotes (3)
  • [F1]The shares are directly held by New Enterprise Associates 16, L.P. ("NEA 16"), and indirectly held by NEA Partners 16, L.P. ("NEA Partners"), the sole general partner of NEA 16, NEA 16 GP, LLC ("NEA 16 GP"), the sole general partner of NEA Partners 16, and the individual managers of NEA 16 GP (NEA Partners 16, NEA 16 GP and the individual managers of NEA 16 GP, together, the "Indirect Reporting Persons").The individual managers of NEA 16 GP are Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad Makhzoumi, Josh Makower, Scott D. Sandell, Peter W. Sonsini and Paul Walker. The Indirect Reporting Persons disclaim beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares of the Issuer held by NEA 16 in which the Indirect Reporting Persons have no pecuniary interest.
  • [F2]On April 3, 2020, NEA 16 exercised a call option to purchase 1,500,000 shares of the Issuer's common stock ("Common Stock") for $0.001 per share. NEA 16 paid the exercise price through the forfeiture of 564 shares of Common Stock.
  • [F3]The call option became exercisable upon the closing of the Issuer's initial public offering.

Issuer

Trevi Therapeutics, Inc.

CIK 0001563880

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001712882

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 9:26 PM ET
Size
12.8 KB